Heart and organs failure is charact...

Heart and organs failure is characterized through an inability of the myocardium to deliver sufficient oxygenated line to meet the needs of tissues during exercise or at peacefulness Because diagnostic criteria for this clinical syndrome remain ill defined, the actual prevalence is difficult to determine. Heart failure is estimated to affect 2 to 45 million ones in the United States. (1-3) The condition is more belonging to all in men than in women and its prevalence increases with age (11 percent in bodily forms 25 to 54 years of age, 37 percent in characters 55 to 64 years, and 45 percent in [i]role[/i]s 65 to 74 years). (3) Heart failure is becoming increasingly usual as the U.S. population ages and survival rates after acute myocardial infarction increase.

The annual direct medical charge of caring for patients with heart failure is estimated to exce $10 billion. (4) Furthermore, heart failure is a progressive condition: one time symptoms appear, subsequent morbidity and mortality are high. In patients with heart failure identified on careful screening, five-year survival rates are alone 59 percent in men and 45 percent in women (5)

This article focuses onward the diagnosis of heart failure from an evidence-based perspective. A clinical review (6) published in this issue examines the treatment of heart failure and the prognosis for affected patients.

Pathophysiology of Heart Failure

Normal myocardial function requires sufficient nutrient-rich, toxin-free family at rest and during exercise; sequential depolarization of the myocardium; normal myocardial contractility during systole and relaxation during diastole; normal intracardiac convolution before contraction (preload); and limited resistance to the spring of blood out of the heart (afterload). The capacity of the heart to adapt to short-term changes in preload or afterload is remarkable, if it were not that sudden or sustained changes in preload (eg acute mitral regurgitation, excessive intravenous hydration), afterload (eg aortic stenosis, inexorable uncontrolled hypertension), or demand (eg increased demand because of simple anemia or hyperthyroidism) may lead to progressive failure of myocardial function. Asymptomatic dysfunction progresse steadily to glaring heart failure.

Coronary artery disease accounts for nearly 70 percent of all cases of heart failure. (7) Les visit often causes include diabetes mellitus and valvular heart disease (Table 1) Heart failure also can be multifactorial. For example, the disease can rise from acute myocardial infarction (los of myocardial contractility) with papillary muscle dysfunction (increased preload) and acute pulmonary edema (hypoxemia).

Heart failure may be classified into six originals based on the role of diastolic or systolic dysfunction (Table 2) Diastolic dysfunction is heart failure caused by way of compromised myocardial relaxation in the demeanor of normal myocardial contractility and ejection fraction. It is associated greatest in quantity commonly with coronary artery disease, hypertension, aging, and infiltrative cardiomyopathy. Systolic dysfunction is caused by means of impaired myocardial contractility and grave ejection fraction. It is associated greatest in quantity often with coronary artery disease (especially myocardial infarction), idiopathic dilated cardiomyopa-thy, hypertension, and valvular disease.

The five protoplasts of heart failure resulting from systolic dysfunction include high output heart failure, grave cardiac output syndrome, right heart failure, left heart failure, and biventricular failure. High output heart failure come to passs when the demand for posterity exceeds the capacity of an otherwise normal heart to adapted the demand. This type of heart failure may arise in patients with severe anemia, arteriovenous malformations with shunting of family or hyperthyroidism. Patients with grave cardiac output syndrome have fatigue and los of lean muscle mass as their greatest in quantity prominent symptoms, but they also may have dyspnea, impaired renal function, or altered mental status. Right heart failure is characterized by dint of peripheral edema, whereas left heart failure is characterized at pulmonary congestion. Both systemic and pulmonary congestion are near in patients with biventricular heart failure.

Although the symptoms, causes, prevalence, and epidemiology of the six different protoplasts of heart failure are somewhat different, there is substantial overlap, and models may coexist. Therefore, this review not past nor futures an approach to diagnosis that is appropriate regardless of the prototype or cause of heart failure.

Overview of Diagnosis

The image of patients who may be suspected of having heart failure ranges from those who are asymptomatic nevertheless at high risk for heart failure (i.e., patients who abuse alcohol or have coronary artery disease, hypertension, diabetes mellitus, frontage to cardiotoxic drugs, or familial history of cardiomyopathy) to those with florid signs and symptoms of heart failure.

Guidelines from the American guild of Cardiology and the American Heart Association (8) identify four stages in the progression of heart failure. Patients in stage A have no structural abnormalities however are at high risk for heart failure. In stage B patients are asymptomatic yet have structural heart disease. Patients in stage C have structural abnormalities and past or at hand heart failure. In stage D patients have end-stage heart failure and require mechanical circulatory support, infusion of inotropic agents, cardiac transplantation, or hospice care.